| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/22/2008 | CA2420999C 2-substituted heterocyclic compounds and their use in treating multidrug resistance |
| 01/22/2008 | CA2382577C Injectable buprenorphine microparticle compositions and their use |
| 01/22/2008 | CA2382535C Mixed micellar pharmaceutical delivery system and method of preparation |
| 01/22/2008 | CA2368348C Biodegradable, injectable oligomer-polymer composition |
| 01/22/2008 | CA2347976C Plastics container containing stabilised drug formulations |
| 01/22/2008 | CA2338728C Pharmaceutical composition for injection based on paracetamol |
| 01/22/2008 | CA2316485C Sustained-release pharmaceutical composition |
| 01/22/2008 | CA2311308C Method for producing solid dosing forms |
| 01/22/2008 | CA2309629C Aqueous suspensions of submicron 9-hydroxyrisperidone fatty acid esters |
| 01/22/2008 | CA2303807C Bioresorbable compositions for implantable prostheses |
| 01/22/2008 | CA2293589C Semisolid pharmaceutical formulation containing dexketoprofen trometamol |
| 01/22/2008 | CA2257133C Human dnase i hyperactive variants |
| 01/22/2008 | CA2245708C Solid formulations containing trehalose |
| 01/22/2008 | CA2240180C Compositions comprising hydroxy-functional polymers |
| 01/22/2008 | CA2222676C New pharmaceutical composition with anaesthetic effect |
| 01/22/2008 | CA2215520C Chlamydia vaccines |
| 01/22/2008 | CA2205136C Improved antiviral prodrugs of phosphonoacids |
| 01/22/2008 | CA2195419C Immunological activity of rhamnolipids |
| 01/22/2008 | CA2158576C Methods and compositions for the prevention or treatment of sexually transmitted diseases |
| 01/17/2008 | WO2008008944A1 Pharmaceutical suspensions comprising phenylephrine and method of preparation |
| 01/17/2008 | WO2008008866A2 Method and apparatus for remotely testing a digital subscriber line access multiplexer |
| 01/17/2008 | WO2008008801A2 Solid oral dosage vitamin and mineral compositions |
| 01/17/2008 | WO2008008733A2 Nanoparticulate sorafenib formulations |
| 01/17/2008 | WO2008008596A2 Method of reducing inflammation |
| 01/17/2008 | WO2008008592A2 Multi-particulate formulation having tramadol in immediate and controlled release form |
| 01/17/2008 | WO2008008544A2 Equine whole food supplements |
| 01/17/2008 | WO2008008474A2 Compositions and methods for the treatment of chronic pain conditions |
| 01/17/2008 | WO2008008434A1 Controlled-release formulations |
| 01/17/2008 | WO2008008373A2 Rhinosinusitis prevention and therapy with proinflammatory cytokine inhibitors |
| 01/17/2008 | WO2008008364A2 Enhanced stability phenylephrine liquid compositions |
| 01/17/2008 | WO2008008139A2 Methods and devices for forming treatment agent carriers |
| 01/17/2008 | WO2008008120A1 Solid form |
| 01/17/2008 | WO2008008057A1 Stable formulation comprising a combination of a moisture sensitive drug and a second drug and manufacturing procedure thereof |
| 01/17/2008 | WO2008007999A1 Anti-tumoral, antibacterial and antiviral pharmaceutical composition (variants) |
| 01/17/2008 | WO2008007991A1 A method for the production of fentanyl - based anesthetics for their oral transmucosal administration in a candy -l ike dosage form |
| 01/17/2008 | WO2008007926A1 Transdermal preparations containing hydrophobic non-steroidal anti-inflammatory drugs |
| 01/17/2008 | WO2008007921A1 Paroxetine hydrochloride-containing sustained-release tablet having reduced dissolution variation |
| 01/17/2008 | WO2008007796A1 Controlled-release drug preparation and method for producing the same |
| 01/17/2008 | WO2008007786A1 Patch and patch preparation |
| 01/17/2008 | WO2008007554A1 Adhesive preparation |
| 01/17/2008 | WO2008007415A1 Inclusion coenzyme q10 and method of producing inclusion coenzyme q10 |
| 01/17/2008 | WO2008007383A1 Dried electrified hydrocolloid gels having unique structure and porosity |
| 01/17/2008 | WO2008007290A2 Core-shell nanoparticles for thearapy and imaging purposes |
| 01/17/2008 | WO2008007157A1 Device applicable to skin for generating carbon dioxide |
| 01/17/2008 | WO2008007152A2 Preparation of pharmaceutical formulations |
| 01/17/2008 | WO2008007151A2 Processes for preparing pharmaceutical compositions |
| 01/17/2008 | WO2008007150A1 Preparation of pharmaceutical compositions |
| 01/17/2008 | WO2008007099A1 A pharmaceutical formulation comprising a beta2-selective adrenorezeptor agonist and / or glucocorticoid and method for the preparation thereof |
| 01/17/2008 | WO2008007092A1 Composition |
| 01/17/2008 | WO2008007046A1 Polyurethane elastomers |
| 01/17/2008 | WO2008007001A1 Injectable slow-release formulation of active ingredients, method for the preparation thereof |
| 01/17/2008 | WO2008006888A1 Combination of adapalene and benzoyl peroxide for treating acne lesions |
| 01/17/2008 | WO2008006716A2 Improvements relating to pharmaceutical compositions |
| 01/17/2008 | WO2008006715A2 Improvements relating to pharmaceutical compositions |
| 01/17/2008 | WO2008006714A2 Improvements relating to biocidal compositions |
| 01/17/2008 | WO2008006713A2 Improvements relating to anti-parasitic compositions |
| 01/17/2008 | WO2008006712A2 Preparation of nanodispersions |
| 01/17/2008 | WO2008006658A1 Hydrogels containing low molecular weight alginates and biostructures made therefrom |
| 01/17/2008 | WO2008006535A2 Use of a cationic colloidal preparation for the diagnosis and treatment of ocular diseases |
| 01/17/2008 | WO2008006534A2 Multiple unit tablets |
| 01/17/2008 | WO2008006528A2 Pharmaceutical compositions comprising levetiracetam |
| 01/17/2008 | WO2008006506A1 Pharmaceutical preparation for oral administration with controlled active ingredient release in the small intestine and methods for its production |
| 01/17/2008 | WO2008006285A1 Stabilization compositions for cysteamine and its hydrochloride and process methods related |
| 01/17/2008 | WO2008006284A1 Use of calcium salt of polyenoic acid in medical and cosmetic field |
| 01/17/2008 | WO2008006226A1 Transdermal formulations of synthetic cannabinoids and nano colloidal silica |
| 01/17/2008 | WO2008006216A1 Anti-inflammatory and cytoprotectant chronotherapy |
| 01/17/2008 | WO2007139936A3 Hyperthermic technologies comprising carbon micro- or nanotubes and therapeutic uses thereof |
| 01/17/2008 | WO2007136830A3 Process for producing nanoparticles by spray drying |
| 01/17/2008 | WO2007131017A3 A METHOD FOR DELIVERING A HUMAN CHORIONIC GONADOTROPIN (hCG) VACCINE FOR LONG-ACTING ANTIBODY PRODUCTION |
| 01/17/2008 | WO2007117661A3 Drug microparticles |
| 01/17/2008 | WO2007115043A8 Valves having corrosion resistant ceramic coating |
| 01/17/2008 | WO2007113762A3 Bulking of soft tissue |
| 01/17/2008 | WO2007109713A3 Dosage forms having a randomized coating |
| 01/17/2008 | WO2007108031A3 An ophthalmic pharmaceutical composition containing amphiphilic polyaspartamide copolymers |
| 01/17/2008 | WO2007108004A3 S-alkylisothiouronium derivatives for the treatment of inflammatory diseases |
| 01/17/2008 | WO2007098408A3 Novel application of topical anesthetics for modulation of neurogenic tremor |
| 01/17/2008 | WO2007089794A3 Methods and compositions for improving the incorporation of orthopaedic and orthodontic implants |
| 01/17/2008 | WO2007075883A3 Transdermal delivery of meptazinol |
| 01/17/2008 | WO2006135373A3 Nano-particle production |
| 01/17/2008 | WO2006127070A3 An edible composition including a delivery system for active components |
| 01/17/2008 | WO2006116718A3 Pharma-informatics system |
| 01/17/2008 | WO2006105126A3 System and method for loading a beneficial agent into a medical device |
| 01/17/2008 | WO2006059180A3 Process of preparation of biodegradable films from semi refined kappa carrageenan |
| 01/17/2008 | WO2006052880A3 Synergistic effects of combined administration of mirtazapine and a stimulant compound |
| 01/17/2008 | WO2006003481A3 Oleaginous pharmaceutical and cosmetic foam |
| 01/17/2008 | WO2002053187A3 Methods and transdermal compositions for pain relief |
| 01/17/2008 | WO2001082875A3 A core formulation |
| 01/17/2008 | US20080015550 Methods and systems for neural maintenance and regeneration |
| 01/17/2008 | US20080015549 System For Processing Medication Restriction Information |
| 01/17/2008 | US20080015507 Rapid Infusion System |
| 01/17/2008 | US20080015488 Glaucoma implant with double anchor mechanism |
| 01/17/2008 | US20080015480 Hemostatic compound and its use |
| 01/17/2008 | US20080015343 Azithromycin dosage forms with reduced side effects |
| 01/17/2008 | US20080015332 Colloidal suspension of submicronic particles for carrying active principles and their mode of preparation |
| 01/17/2008 | US20080015155 Compositions and Methods for the Treatment of Inflammatory Conditions of the Mucosae, Skin and the Eye |
| 01/17/2008 | US20080014601 Controller for a blood parameter testing system and method of testing therefor |
| 01/17/2008 | US20080014286 Metal-containing materials |
| 01/17/2008 | US20080014281 Chitin Micro-Particles As An Adjuvant |
| 01/17/2008 | US20080014280 Amorphous pregabalin and process for the preparation thereof |
| 01/17/2008 | US20080014279 adding bioactive particles consisting of bioactive glass to solution comprising at least one high molecular weight biodegradable polymer, precipitating the polymer, thereby forming bioactive particles individually microencapsulated coated with high molecular weight polymer such as porcine gelatin |